News

December 6, 2019December 6, 2019

Repeat Coding in Gene Region Linked to Risk of Late-onset Alzheimer’s, Study Suggests

News

Longer sequence repeats in or near two genes may be linked to a higher risk of late-onset Alzheimer’s disease, a study reports. The study “Alzheimer Disease Pathology-Associated Polymorphism in ... Read more

December 4, 2019December 4, 2019

First Patient Dosed in INmune Bio’s Phase1b Trial Testing XPro1595 Anti-inflammatory Compound for Alzheimer’s

News

INmune Bio has dosed the first patient in its Phase 1b trial (NCT03943264) testing the safety and efficacy of its next-generation anti-inflammatory compound XPro1595 for Alzheimer’s disease (AD). The ... Read more

December 3, 2019December 3, 2019

Trials into Possible Treatment for Agitation in Alzheimer’s Patients to Continue, Avanir Says

News

A potential oral treatment for agitation due to Alzheimer’s dementia, AVP-786, will continue in advanced clinical testing after a fuller analysis of data from two completed Phase 3 trials, Avanir Pharmaceuticals said. ... Read more

December 2, 2019December 2, 2019

Bluefield Project to Cure Frontotemporal Dementia Gets $1.2M to Advance FTD Blood Testing

News

The Bluefield Project to Cure FTD will receive $1.2 million from the Alzheimer’s Drug Discovery Foundation (ADDF) to validate an exploratory blood test in frontotemporal dementia (FTD). The award is ... Read more

November 27, 2019November 27, 2019

Phase 2/3 Trial of Oral Troriluzole in Easing Alzheimer’s Dementia Fully Enrolled

News

Biohaven announced that its Phase 2/3 study of the investigational oral therapy troriluzole (BHV-4157) in treating symptoms of mild to moderate Alzheimer’s disease (AD) has fully enrolled more than 700 ... Read more

November 26, 2019November 26, 2019

Phase 2 Trial to Test New Way of Measuring Tau Plaques in Living Brains

News

A newly opened Phase 2 clinical trial will test the sensitivity of new imaging tool for plaque buildup in the brains of people with mild cognitive impairment and dementia ... Read more

November 25, 2019November 25, 2019

Alzheimer’s Association, AME Church Join to Promote Disease Awareness and Support

News

The Alzheimer’s Association and the African Methodist Episcopal Church (AME Church) announced a three-year partnership to promote greater involvement in the fight against Alzheimer’s (AD) and to heighten awareness ... Read more

November 22, 2019November 22, 2019

Enrollment Complete for Clinical Trial of LymPro, an Alzheimer’s Investigational Blood Diagnostic Test

News

The second part of a clinical study evaluating the use of a blood diagnostic test for Alzheimer’s disease — called the Lymphocyte Proliferation Test (LymPro Test) — is now fully ... Read more

November 20, 2019November 20, 2019

$1.34M Grant Will Be Used to Broaden Psychosocial Research into Dementia Care

News

The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance care and support for those with Alzheimer’s disease (AD) or other ... Read more

November 19, 2019November 19, 2019

UW Scientist Awarded $17.2M Grant to Study Link Between Eye Health and Alzheimer’s

News

A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National Institute on Aging (NIA) grant to study whether degenerative eye diseases ... Read more

Pin It on Pinterest